Pharmacotherapy for AMD: state-of-the-art
<p> <i>The article discusses the evolution of the treatment for a socially important disease, age-related macular degeneration (AMD). Data on earlier and recent treatment for “wet” AMD as well as promising trends in the development of novel medications are addressed. </i>...
Main Authors: | I.A. Koroleva, A.A. Gvetadze, T.B. Romanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2019-07-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/1dd/1dd996701caf108cbadb5353455c5931.pdf |
Similar Items
-
Influence of the morphology metrics of serous PED in AMD on the success of triamcinolone acetonide monotherapy
by: T.B. Kustryn
Published: (2016-12-01) -
Pharmacotherapy of small cell lung cancer: Current state-of-the-art
by: Tatyana A. Berezhnova, et al.
Published: (2023-03-01) -
Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development
by: A. A. Lidzhieva, et al.
Published: (2018-02-01) -
Changes in structural and functional retinal features resulting from the effect of a long-acting steroid in serous PED associated with AMD: a 36-month follow-up study
by: T.B. Kustryn, et al.
Published: (2016-10-01) -
The complex model of risk and progression of AMD estimation
by: V. S. Akopyan, et al.
Published: (2014-07-01)